Dr. Christopher Patrick Scally, MD

Dr. Scally practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Scally's NPI, 1477872133, was assigned on May 20, 2010. Dr. Scally graduated from Vanderbilt University School Of Medicine in 2010. Dr. Scally holds Texas license R3425.

Dr. Scally's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Scally's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scally practices. Vendor and product names are available with a free account.

Surgery is Dr. Scally's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Scally is board certified in complex general surgical oncology by the American Board of Surgery. Dmand AI has Dr. Scally's licenses on file in 11 states: Texas, Florida, Arizona, Mississippi, Oklahoma, Tennessee, Washington, Alabama, Georgia, Louisiana and Michigan.

Dmand AI lists colon removal and esophagus, stomach, or upper small intestine surgery among the conditions Dr. Scally treats.

CMS data shows 113 Medicare services from Dr. Scally across 2 procedure codes in 2024, all of them office visits, for 100 Medicare patients. Medicare paid $7,910 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 100 Medicare patients who saw Dr. Scally in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Scally's median patient age at 70, with 43% women.

In 2018, Dr. Scally wrote 17 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $33 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Scally for performance year 2024, reported as part of a group. Dr. Scally accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 62 papers to Dr. Scally, published from 2013 to 2025. 2015 was the busiest year, with 12. The most frequent topics are Internship and Residency, Sarcoma and General Surgery. Dr. Scally has published most often in Ann Surg Oncol. Dr. Scally's most frequent co-authors are Christina Lynn Roland, MD, Emily Zhi-Yun Keung, MD and Keith Francis Fournier, MD.

Dmand AI links Dr. Scally to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 8 general payments to Dr. Scally from 1 drug or device company from 2021 to 2022. Education make up the largest share, 71% of the total. Intuitive Surgical, Inc. paid the most, $4,206.

Dmand AI lists 1 award for Dr. Scally.

Dr. Scally graduated from Vanderbilt University School Of Medicine in 2010. Dr. Scally is a member of ACS.

Dr. Scally is in network with 5 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.